\begin{enumerate}
    \item EUA. Tests performed under FDA Emerging Use Authorization.
    \item LDT. Laboratory Developed Tests performed under CLIA regulations.
    \item IRB. Tests performed as part of a research study conducted under Institutional Review Board (IRB) approval for human subjects research.
    \item Surveillance. These tests are subject to constraints on the reporting of individual test results: explicit positive/negative results are not returned as if from a CLIA lab. Instead, patients with a positive result are referred to a CLIA testing facility.
\end{enumerate}